Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_623_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
65 Мб
Скачать
The thyroid 405
https://t.me/medicina_free
diameter in the absence of lymph node metastasis. In addition, it may also be adequate for follicular tumours with minimal capsular invasion, small tumour size and no metastatic disease. Most other patients with differentiated thyroid cancer will require total thyroidectomy and possible radioiodine therapy.
Radioiodine ablation (RAI)
Iodine- 131 ablation of the thyroid bed and remnant is an essential component of the treatment of differenti­ated thyroid cancer. The majority of differentiated thyroid cancers retain the capacity to take up and concentrate iodine. This permits radioactive isotopes of iodine to be used both for the localization and treatment of residual or metastatic thyroid carci­noma. By removing and then ablating all thyroid tis­sue, follow­later in this chapter).
Complications of swelling, or thyroiditis in those patients with a large thyroid remnant. In addition, radiation sialadenitis affecting the parotid or submandibular glands may present with painful swelling of the affected salivary gland(s) after eating. There are few long- term seque­lae from radioiodine providing that the cumulative dose is kept to a minimum.
up using thyroglobulin is possible (see
131
I therapy include oedema and
TSH suppression
Recurrence rates are reduced by postoperative levo­thyroxine therapy. Patients who have not required RAI do not need TSH suppression and the serum TSH should be maintained in the low- normal range between 0.3 and 2.0 mU/l. Following initial treat­ment with total thyroidectomy and RAI, and before evaluation of the patient’s response to treatment after 9–12 months, TSH should be suppressed to below 0.1 mU/l in all patients. Following evaluation of response after 9–12months after total thyroid­ectomy and RAI, the risk of thyroid cancer recur­rence should be reclassified according to the criteria
for Dynamic Risk Stratification. This restratification should enable the degree of TSH suppression to be adjusted accordingly.
Thyroglobulin
Serum thyroglobulin is the best way of detecting the presence of normal or malignant thyroid tissue and most patients who are free of disease will have unde­tectable levels. In patients in whom the thyroglobulin rises during follow­and whole­look for local or systemic recurrence.
up, careful clinical examination
body scanning should be performed to
Medullary carcinoma
Phaeochromocytoma and hyperparathyroidism should be excluded. All patients with medullary carcinoma require total thyroidectomy and central lymph node dis­section. Radical neck dissection may be required when cervical lymphadenopathy is present.
Prophylactic thyroidectomy is indicated in unaf­fected kindred members with the germline RET mutation, even in childhood.
Anaplastic carcinoma
This condition has a very poor prognosis with a 1- year survival of <15%. The main aim of treatment following diagnosis is local control of the disease. Useful pallia­tion may be achieved with external beam radiother­apy, and tracheostomy should be avoided if at all possible.
Additional resources
Case 104: A lump in the neck that moves on swallowing Case 105: A woman with an obvious endocrine disease Case 106: A mass of cervical lymph nodes Case 107: A rapidly enlarging mass in the neck
4040
https://t.me/medicina_free
The parathyroids
Ekpemi Irune
Learning objective
To understand the presentations of both hypoparathyroidism and
hyperparathyroidism and their management.
of calcium (and magnesium) from the distal
Anatomy and development
The parathyroids are four endocrine glands (some­times three or five) about the size of peas, which usu­ally lie in two pairs behind the lateral lobes of the thyroid gland. The superior parathyroids arise from the fourth branchial pouch and owing to their short migration can usually be found posterior to the upper two-
thirds of the thyroid. The inferior glands arise from the third pouch in association with the develop­ing thymus (see Figure 39.1). The inferior parathy­roids may lie almost anywhere in the neck or superior mediastinum although the majority lie within 1cm of the lower thyroid pole.
tubules is reciprocally increased.
2
It activates the 1α- hydroxylase enzyme in the
kidney, which converts the inactive 25-hydroxy­cholecalciferol (25- hydroxy- vitamin D) into 1,25- dihydroxycholecalciferol. The resultant acti­vated 1,25 form of vitamin D facilitates intestinal absorption of calcium.
3
It stimulates osteoclastic activity in the bones,
resulting in the decalcification and liberation of excessive amounts of calcium and phosphate in the blood.
Effects ofincreased PTHproduction
Physiology
The parathyroids produce parathormone (PTH), which has a profound influence on calcium and phosphate metabolism. There are three main effects.
It increases the excretion of phosphate from the
1
kidney by inhibiting its tubular reabsorption (phosphaturic effect); active tubular reabsorption
Ellis and Calne’s Lecture Notes in General Surgery, Fourteenth Edition. Edited by Christopher Watson and Justin Davies. © 2023 John Wiley & Sons Ltd. Published 2023 by John Wiley & Sons Ltd. Companion website: www.wiley.com/go/Watson/GeneralSurgery14
• A raised serum calcium and a lowered serum phosphate.
• An increased excretion of phosphate in the urine (phosphaturic effect of PTH).
An increased excretion of calcium in the urine.
• The large amount of calcium filtered (owing to the hypercalcaemia) exceeds the capacity of the tubules to reabsorb it all, so increased calcium excretion occurs.
In the longer term, it causes increased osteo-
clastic activity, with a raised serum alkaline phosphatase associated with decalcification of the bones.
The parathyroids 407
https://t.me/medicina_free
Hypoparathyroidism
Lack of PTH results in low serum calcium. This leads initially to paraesthesiae (perioral and fingertips) then hyperirritability of skeletal muscle with carpo­pedal spasms, the syndrome being called tetany. The most common cause of this is removal or bruising of the parathyroids during thyroidectomy (see Chapter39). Tetany is liable to occur if the serum cal­cium falls below 1.5mmol/L.
Clinical features
Spasms may affect any part of the body, but typically the hands and feet. The wrists flex and the fingers are drawn together in extension, the so­d’accoucheur’. This spasm may be induced by placing a tourniquet around the arm for a few minutes (Trousseau’s sign muscles may be demonstrated by tapping over the facial nerve, which results in spasm (Chvostek’s
2
sign
).
Note that clinical tetany may occur with a normal level of serum calcium in alkalosis (e.g. overbreath­ing, excessive prolonged vomiting) because of a com­pensatory shift of ionized calcium to the unionized form in the serum.
1
). Hyperirritability of the facial
called ‘main
either no symptoms or non­including fatigue, depression and weakness; less commonly, it is detected during the investigation of nephrolithiasis or osteopenia (e.g. on dual-
ray absorptiometry [DEXA] testing), the two
X­main complications of hyperparathyroidism. Many ‘asymptomatic’ patients feel much better after treatment. The annual incidence is highest among women in the 5th and 6th decade of life (2 per 1000 population).
specific symptoms
energy
Pathology
In 85–90% of patients, primary hyperparathyroidism is due to a solitary hyperfunctioning parathyroid adenoma. The lower glands are affected more com­monly than the upper ones. In 10% of cases, the cause of primary hyperparathyroidism is familial with thepresence of multiglandular hyperplasia. This may be associated with multiple endocrine neoplasia (MEN) type I, MEN type II and MEN type IV (Box40.1) or may be sporadic or induced by long­intake, radiotherapy to the neck and calcium supple­mentation. More rarely, hyperparathyroidism­tumour syndrome is an inherited cause of hyperpar­athyroidism, which is also linked with maxillary and antral fibro­tumours.
osseous tumours and renal and uterine
term lithium
jaw
Hyperparathyroidism
There are four distinct types of pathologically increased PTH secretion: primary, secondary, ter­tiary and that due to ectopic PTH production by tumours.
Primary hyperparathyroidism
The diagnosis of primary hyperparathyroidism is made following the detection of hypercalcaemia in the presence of inappropriately normal or elevated circulating PTH levels; the PTH should be low if cal­cium is raised. The hypercalcaemia is usually discov­ered on routine screening of patients who have
1
Armand Trousseau (1801–1867), Physician, Hôpital Necker, Hôpital St Antoine and Hôpital Dieu, Paris, France. Also described thrombophlebitis migrans associated with cancer.
2
Frantisek Chvostek (1835–1884), Physician, Josefs­Akademie, Vienna, Austria.
Parathyroid carcinoma
Parathyroid carcinoma is a very rare condition and accounts for less than 1% of all cases of primary hyperparathyroidism. Patients often have higher serum calcium and PTH levels and are more likely to have a palpable neck mass than those with benign hyperparathyroidism. There is an association with previous neck irradiation and the MEN type 1 syndrome.
Surgery is the only effective treatment. Malignancy should be considered with any gland that is firm, has a grey appearance or that is adherent to surrounding structures. If malignancy is confirmed, surgery may involve simple excision or en bloc resection, includ­ing excision of local structures such as ipsilateral thyroid, lymph nodes, thymus, strap muscles and the recurrent laryngeal nerve. Approximately 30% of tumours will metastasize, but death from the disease is usually attributable to hypercalcaemia and its effects on the heart, pancreas and kidney, rather than metastatic tumour burden.
408 The parathyroids
https://t.me/medicina_free
Box 40.1 Multiple endocrine neoplasia (MEN)
syndromes
These syndromes are characterized by the development of tumours in two or more endo­crine structures in the same patient. These may be endocrine adenomas or adenocarcinomas. Some, such as medullary carcinoma of the thyroid, may be familial, with autosomal dominant inheritance.
MEN type I
Pancreatic tumour: islet cell tumours except β- cell tumours (insulinoma).
Hyperparathyroidism.
Pituitary tumour, e.g. prolactinoma.
Adrenocortical tumour.
Secondary hyperparathyroidism
In some 10% of patients with hyperparathyroidism, the condition is found to be due to hyperplasia of all four parathyroid glands. This occurs most commonly in patients with renal failure maintained by dialysis, in whom renal conversion of 25-hydroxycholecalciferol (calcidiol) to 1,25-dihy­droxycholecalciferol (calcitriol) is impaired. This active form of vitamin D is required for absorption of calcium from the gut; deficiency results in hypocal­caemia, which chronically stimulates PTH produc­tion. The parathyroid glands undergo hyperplasia in response. To prevent this, dialysis patients are rou­tinely given 1α-
hydroxycholecalciferol (alphacalcidol),
so bypassing renal 1α- hydroxylase.
Tertiary hyperparathyroidism
Prolonged secondary hyperparathyroidism leads to autonomous PTH production, which continues even after renal transplantation replaces the previously deficient renal 1α- hydroxylase conversion step. Total parathyroidectomy is required.
Ectopic PTH production
Hyperparathyroidism is occasionally due to ectopic PTH production by tumours, such as squamous carci­noma of the bronchus.
MEN type II
Medullary carcinoma of the thyroid.
Phaeochromocytoma.
Hyperparathyroidism.
MEN type III (also known astype IIB)
Medullary carcinoma of the thyroid.
Phaeochromocytoma.
Neurofibromas of tongue, lips and eyelid.
Marfanoid appearance.
MEN type IV
Hyperparathyroidism.
Anterior pituitary tumours.
Adrenocortical tumours and renal tumours.
Tumours of the reproductive organs (e.g. neuroen­docrine tumour of the cervix and uterine tumours).
Clinical features of hyperparathyroidism
These depend on the results of excessive production of PTH by the tumour (see earlier in this chapter). Presenting symptoms may include the following.
Renal effects: renal stones, infection associated
• with renal calculi, calcification in the renal sub­stance (nephrocalcinosis) or uraemia. Urinary tract calculi are the most common clinical mani­festation of hyperparathyroidism. It is important to remember that chronic renal disease with impaired excretion of phosphate may result in secondary hyperplasia of the parathyroid glands with features similar to those of a primary adenoma of the parathyroid.
Bone changes: spontaneous fractures or pain in the bones. X- ray will show decalcification of the bones with cyst formation. The weakened bones may be deformed; this condition is known as osteitis fibrosa cystica or von Recklinghausen’s disease bone. There may be metastatic calcification in soft tissues, arterial walls and the kidneys.
Abdominal pain: constipation is common.
Dyspepsia or frank peptic ulceration is also
3
Friederich Daniel von Recklinghausen (1833–1910), Professor of Pathology, successively at Königsberg, Germany; Würzburg, Germany; and Strasbourg, France. He also described neurobromatosis.
3
of
sometimes associated with parathyroid adenoma,
https://t.me/medicina_free
as is pancreatitis. If ulcer symptoms persist after treatment of the adenoma, the presence of a gas­trinoma should be excluded by serum gastrin assay (there is an MEN syndrome association).
Vague ill health associated with high serum cal- cium: the patient very often complains of lassitude, mental disturbances, weakness, anorexia and loss of weight. Thirst and polyuria are common.
Cardiovascular: hypertension may be noted at the
• initial diagnosis and is often associated with left ventricular hypertrophy. Although serum PTH correlates strongly with left ventricular mass, the reduction in left ventricular mass following par­athyroidectomy is not associated with a similar reduction in mean blood pressure. Primary hyper­parathyroidism appears to be associated with an increased rate of premature death owing to cardi­ovascular disease, although early surgical inter­vention may result in improved survival.
Asymptomatic: an increasing number of patients
with very few or no symptoms are now being diag­nosed on routine biochemical screening. Despite this, the majority of these patients feel better fol­lowing parathyroidectomy and this, combined with a recognition that up to 25% of patients will have progressive disease, has led to support for early sur­gical intervention following initial diagnosis.
A careful family history should also be taken to exclude MEN and this, or presentation of primary hyperparathyroidism at an early age, should raise the suspicion of hyperplasia rather than an adenoma.
The main effects have historically been summarized as: ‘stones, bones, abdominal groans, mental moans’.
The parathyroids 409
Serum urea and creatinine should be measured to
• assess renal function.
Tc99m- Sestamibi (methoxyisobutylisonitrile [MIBI])
parathyroid scintigraphy will identify a solitary par­athyroid adenoma and highlight an ectopic retros­ternal location. Sestamibi is technetium­MIBI and, following injection, is taken up by para­thyroid glands and retained by adenomas.
Ultrasound of the neck is also effective in local-
izing an adenoma. In clinical practice, surgeons look for concordance between two imaging modalities to improve the preoperative localiza­tion of parathyroid tumours. This is often by pooling ultrasound and sestamibi imaging outcomes.
Renal ultrasound may be implemented to exclude
• kidney stones.
Computed tomography (CT) scan, with images
• before and repeated several times after contrast administration, may also show up ectopic adeno­mas, which take up contrast rapidly.
4- Dimensional- CT (4D- CT) scanning is a modern imaging technique that has higher reported sensi­tivity of up to 79.8% in detecting single, multiple and ectopic parathyroid gland disease.
Genetic Testing is an essential part of diagnostic screening in all patients with a family history of hyperparathyroidism, patients < 35 years of age presenting with hyperparathyroidism or those < 45 years with evidence of multigland disease, suspected jaw tumour syndrome and/or gland hyperplasia. There are specific national guide­lines that underpin genetic testing in this population.
99- labelled
Special investigations
Diagnostic investigations include the following.
Serum calcium and PTH. A high serum calcium, corrected for plasma albumin, in the presence of detectable serum PTH should raise a strong suspi­cion of primary hyperparathyroidism. The PTH may be normal or elevated but in either case is inappropriately elevated for the level of serum calcium.
Serum phosphate may be low (hypophosphatae­mia) and phosphaturia may also be present.
24- hour urine collection for calcium should be taken to exclude familial hypocalciuric hypercal­caemia (FHH).
Medical management
Patients with primary hyperparathyroidism may be managed medically with oral medication such as Cinacalcet. This is a calcimimetic that is a calcium sensing receptor (CaSR) agonist. Stimulation of CaSR results in inhibition of PTH synthesis and secretion thus leading to a reduction in serum calcium concentrations.
Fracture risks in patients can be managed using a bisphosphonate taken orally. This approach is espe­cially suitable in patients who are not medically fit for surgery or where surgery has been unsuccessful. Medical management must be directed under the care of an endocrinologist.
410 The parathyroids
https://t.me/medicina_free
Indications forsurgery
Surgery should be considered in any patient once a diagnosis of primary hyperparathyroidism has been confirmed and even patients with mild hypercalcae­mia get symptomatic benefit following surgery. This is subject to the patient being medically fit enough to undergo general anaesthesia.
Bilateral neck exploration
This procedure is normally carried out using endotra­cheal intubation and neck extension to facilitate access to the neck. Bilateral neck exploration is carried out through a transverse (Kocher’s the clavicle to provide access to both retrothyroid spaces to detect and remove one or more enlarged glands.
If a single gland is enlarged, it is likely to be an ade­noma and is removed once the remaining glands have been visualized and confirmed to be normal. Frozen section of the gland, or urgent ‘near patient’ estimation of PTH levels, will confirm the tissue removed during surgery contains parathyroid tissue. Frozen section will not distinguish between an ade­noma or a carcinoma. Robust pathological assess­ment of the entire gland is required to achieve this.
4
) incision just above
Unilateral neck exploration
Most (95%) patients with primary hyperparathy­roidism have a single affected gland. Preoperative localization of the adenoma by ultrasound of the neck and/or sestamibi scanning (or where available 4D­CT) enables unilateral neck exploration. Patients with multigland disease, MEN- related hyperplasia, FHH and renal disease are not suitable for this approach. In addition, patients with a short neck and previous neck surgery or irradiation may also not be suitable.
formed under either general anaesthesia or local anaesthetic cervical block as a day case. This technique can be combined with intraoperative PTH measure­ment, a fall of at least 50% indicating removal of all hyperfunctioning parathyroid tissue.
Minimally invasive parathyroidectomy
This relies on the use of an incision of about 2.5cm in the neck. In some cases, access is gained through a remote site such as in the transaxillary approach. Specially designed ports are inserted in strategic loca­tions to avoid placing a scar in the neck and endo­scopes may be used in the case of video- assisted parathyroidectomy. These procedures are compara­ble to open procedures in terms of achieving curative outcomes in parathyroid surgery. Patient selection and surgeon experience are crucial to success. In some cases, a minimally invasive procedure may be converted to an open neck procedure when chal­lenges that cannot be remedied using a minimally invasive approach arise intraoperatively.
Complications ofparathyroid surgery
The main complications of parathyroid surgery include:
Recurrent laryngeal nerve palsy: occurs in under
1% of patients.
Hypocalcaemia: the remaining parathyroid glands
• are suppressed by the high PTH levels and may take some time to recover.
Persistent hypercalcaemia: residual parathyroid
tissue remains, possibly a fifth gland or an ectopic gland within the anterior mediastinum.
Focused parathyroidectomy
Following accurate preoperative localization of single gland disease, exploration is carried out through a small incision lateral in the neck which may be per-
4
eodore Kocher (1841–1917), Professor of Surgery, Bern, Switzerland. He won a Nobel Prize in 1909 for work on the thyroid gland. In addition to the thyroid incision, he also described a subcostal incision for open cholecystectomy and a posterior approach to the hip.
Management ofpersistent or recurrent primary hyperparathyroidism
Despite careful initial surgery, a number of patients will not be cured following initial surgery or will relapse at a later stage. This is most often due to a failure to diagnose multigland disease or the presence of an ectopic parathyroid gland. Failure of primary surgery often raises the prospect of revisional surgery. These patients require extensive imaging (ultrasound, sestamibi, CT and MRI scans) prior to surgery to
The parathyroids 411
https://t.me/medicina_free
localize and remove the abnormal gland(s). Selective venous sampling, with PTH measurement by cathe­terization of the venous tributaries in the neck, may also help localization and is often combined with arteriography.
Additional resources
Case 108: A patient with colic and its underlying endocrine cause
4141
https://t.me/medicina_free
The thymus
Christopher Watson
Learning objective
To have knowledge of the tumours of the thymus and their association
with myasthenia gravis.
The thymus gland controls the development of T lymphocytes in the embryo and neonate and lies in the anterior mediastinum between the sternum in front and great vessels and pericardium posteriorly.
Following puberty, the thymus involutes and becomes a fat- infiltrated remnant but to the surgeon, it is of importance in having an ill­nection with myasthenia gravis and being a rare site of mediastinal tumour.
understood con-
Tumours
Tumours of the thymus are of complex pathology; they may arise either from the epithelium (Hassall’s corpus-
1
cles
) and are termed ‘thymomas’, or from lymphoid tissue, or a mixture of both. Thymic tumours typically have solid and cystic components, and may be benign thymomas, or malignant and rapidly invasive thymic carcinomas. Peak incidence is between the fifth and seventh decades. The thymus may also be involved in cases of lymphoma, particularly Hodgkin’s disease. Neuroendocrine tumours may occasionally originate
1
Arthur Hassall (1817–1894), Physician, Royal Free Hospital, London, UK. He published the rst textbook on histology in English.
Ellis and Calne’s Lecture Notes in General Surgery, Fourteenth Edition. Edited by Christopher Watson and Justin Davies. © 2023 John Wiley & Sons Ltd. Published 2023 by John Wiley & Sons Ltd. Companion website: www.wiley.com/go/Watson/GeneralSurgery14
in the thymus and may produce vasoactive substances akin to those produced in carcinoid syndrome.
Clinical features
There are three modes of presentation:
1
A mediastinal mass: Incidental finding on chest
imaging.
Local symptoms of a mass in the mediastinum:
2
Chest pain, breathlessness, phrenic nerve palsy or obstruction of the superior vena cava.
3
Paraneoplastic syndromes: Autoimmune conditions
such as myasthenia gravis and pure red cell apla­sia, or immunodeficiency syndromes.
Treatment
Treatment is by thymectomy via median sternotomy, combined with radiotherapy and/or chemotherapy if malignant, to prevent mediastinal recurrence.
Early invasion, with no more than pleural and mediastinal fat involvement (stage 1), carries a good prognosis (90% at 5 years); involvement of the peri­cardium, great vessels or lung has a poor prognosis.
Myasthenia gravis
This condition is characterized by weakness of skele­tal muscle caused by autoantibodies directed against the postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction, as a consequence of
The thymus 413
https://t.me/medicina_free
which the motor endplate becomes refractory to the action of acetylcholine. About 15% of cases are associ­ated with a tumour of the thymus, whereas thymic hyperplasia is present in most of the remaining cases.
Clinical features
Women are twice as commonly affected as men, and the disease usually commences in early adult life. The extrinsic ocular muscles are most often affected and may indeed be the only ones involved, with ptosis, diplopia and squint. The affected muscles become weak with use and recover, partially or completely,
after rest. The voice is weak and death may eventually occur from respiratory muscle failure.
Treatment
The majority of cases are controlled by choline esterase inhibitors, for example pyridostigmine, with immuno­suppression also having a role in resistant cases.
If a thymoma is present, it is excised, although such tumours are often locally invasive. Thymectomy is otherwise indicated if the disease is progressive and the prognosis is best in young women (under the age of 40 years) with a history of 5 years or less.
4242
https://t.me/medicina_free
The adrenal glands
Vasilis Kosmoliaptsis
Learning objective
To know the physiology of the adrenal (suprarenal) glands and
functional and non­parts of the gland, and their management.
functional tumours that derive from the separate
The adrenal glands are paired glands situated above and medial to the upper pole of each kidney. The cor­tex derives from the mesoderm of the urogenital ridge, while the medulla derives from neural crest ectoderm. These different origins account for the different physiology of medulla and cortex, and the different pathology encountered surgically.
Physiology
Adrenal cortex
The adrenal cortex secretes three groups of steroids:
Glucocorticoids (from the zona fasciculata), which
1
regulate carbohydrate metabolism, protein break­down and fat mobilization.
2 Androgenic corticoids (from the zona reticularis),
which are virilizing.
3 Mineralocorticoids (from the zona glomerulosa),
which regulate mineral and water metabolism. Aldosterone acts to retain sodium and water and to excrete potassium.
Glucocorticoids and androgens are under hypotha­lamic control via adrenocorticotrophic hormone (ACTH) secreted by the anterior pituitary gland;
Ellis and Calne’s Lecture Notes in General Surgery, Fourteenth Edition. Edited by Christopher Watson and Justin Davies. © 2023 John Wiley & Sons Ltd. Published 2023 by John Wiley & Sons Ltd. Companion website: www.wiley.com/go/Watson/GeneralSurgery14
mineralocorticoids are under the control of the renin–angiotensin system (see Chapter 13). As the steroids share a similar biochemical structure, it is not surprising that there is some overlap in actions; thus, hydrocortisone (cortisol), a glucocorticoid, also affects salt and water metabolism and has sex steroid effects (acne, hirsutism) if given in large amounts.
Adrenal medulla
The adrenal medulla is richly innervated with sympa­thetic preganglionic fibres, and produces the catechola­mines adrenaline (epinephrine) and noradrenaline (norepinephrine) in response to autonomic stimulation.
Pathology
The main pathologies affecting the adrenal gland can be categorized based on whether they lead to increased function, owing to tumour or hyperplasia; decreased function, owing to atrophy, infarction or removal; or abnormal function, owing to enzyme disorders.
Increased function
Glucocorticoids (Cushing’s syndrome): adrenocor­tical adenoma; ACTH- producing pituitary ad enoma; ectopic ACTH production (paraneoplastic).
Androgenic corticoids: virilism (the adrenogenital syndrome).
Mineralocorticoids: primary hyperaldosteronism (Conn’s syndrome).
Catecholamines: phaeochromocytoma.